Navigation Links
AVT Developed and Integrated System Featured on KTLA News
Date:1/17/2012

HOLLYWOOD, Calif., Jan. 17, 2012 /PRNewswire/ -- AVT, Inc. (Ticker: AVTC) (www.autoretail.com) had had one of their automated systems featured on KTLA News in a segment discussing the future of prescription medicine dispensing.

The AVT developed Medbox™ Rx Prescription Dispensing System was on display, and a company spokesperson described how the process works.

The story stated that when a customer drops off their prescription at the pharmacy, the pharmacist will ask if they want to pick up their medicine at the counter or at the automated, self-serve system. If the customer opts to pick up their prescription at their convenience from the Medbox™ Rx system, the pharmacist will place the medicine in one of 200 individual lock boxes. The customer will access the lock box by swiping their special identification card and passing a fingerprint recognition scan.

AVT developed the system in partnership with Medbox, and it is the world's first medical dispensing system to feature a patented biometric fingerprint recognition program, which assures patient identity and provides military grade security. The system also takes a photograph of each person conducting a transaction, and provides an unalterable record of every operation.

AVT is also developing other automated retailing systems that use biometric security systems to increase safety, enhance consumer and merchant confidence, and reduce fraud.

To view the KTLA News Story, please visit: http://www.ktla.com/videogallery/67358629/News/KTLA--Medicine-Vending-Machine

For more information on AVT, please call 877.424.3663 or visit the website at www.autoretail.com.

About AVT:

AVT, Inc. is a leading developer of automated and self-service retailing systems. AVT is able to work with any size company to design a custom automated retailing solution that drives traffic, increases sales, improves security, and lowers overhead. With an in-house design team, software developers, mechanical engineers and on-site manufacturing, AVT can take projects from concept to completion with speed, economy and ingenuity.

AVT's stock is traded through the OTC Markets, Ticker Symbol: AVTC:PK

For more information on AVT or the Automated Retailing Industry, visit www.autoretail.com.


'/>"/>
SOURCE AVT, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
2. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
3. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
4. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
5. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
6. More Than 300 New Medicines Being Developed for Mental Illnesses
7. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
8. Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists
9. DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
10. deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimers and Other Cognitive Disorders
11. Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017 /PRNewswire/ - INVICTUS MD STRATEGIES ... FRA: 8IS) Invictus MD is pleased to announce it ... for trading on the TSX Venture Exchange.  ... follows a year of significant achievements for Invictus-MD. Some ... test crops at AB Laboratories Inc. ("AB Labs"), a ...
(Date:3/27/2017)... -- The global clinical chemistry analyzers ... 2025, according to a new study by Grand View ... anticipated to be responsible for the high urgency to ... for growth during the forecast period. In addition, growing ... susceptible to chronic diseases, is presumed to impel the ...
(Date:3/27/2017)...  Twist Bioscience, a company accelerating science and innovation ... raised an additional $33 million. To date, Twist Bioscience ... "It is an exciting time to be leading ... to deliver industry-leading gene volume to our customers, enabling ... Leproust, Ph.D., CEO of Twist Bioscience. "We welcome the ...
Breaking Medicine Technology:
(Date:3/27/2017)... WI (PRWEB) , ... March 27, 2017 , ... ... new patients for custom smile makeovers without requiring a referral. Trimble ... orthodontics, gum disease treatment, cosmetic dentistry and dental implants. Whether patients have discolored, ...
(Date:3/27/2017)... ... 2017 , ... This is the second major release since ... 2014. It is the culmination of collaborative efforts by members of the OSEHRA ... Member Zato Health co-funded the ONC certification and provided key technical support throughout ...
(Date:3/27/2017)... MA (PRWEB) , ... March 27, 2017 , ... ... Group, the organization behind the New England Journal of Medicine and NEJM Journal ... NEJM Knowledge+ Pediatrics Board Review was created by a panel of pediatricians from ...
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may ... of groin injury, it occurs when the muscles around the pelvis become inflamed. ... around the lower torso, as well as accompanying tenderness and weakness. Without proper ...
(Date:3/27/2017)... Atlanta, Georgia (PRWEB) , ... March 27, 2017 ... ... pleased to announce that for a second year in a row; they are ... leading healthcare designers in the industry voted on the award at Design Connections ...
Breaking Medicine News(10 mins):